These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7811037)

  • 1. Nucleotide analogs related to acyclovir and ganciclovir are effective against murine cytomegalovirus infections in BALB/c and severe combined immunodeficient mice.
    Smee DF; Sugiyama ST; Reist EJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2165-8. PubMed ID: 7811037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent anti-murine cytomegalovirus activity and reduced nephrotoxicity of ganciclovir cyclic phosphonate.
    Smee DF; Reist EJ
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1964-6. PubMed ID: 8843317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
    Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of 9-[[(ethoxyhydroxyphosphinyl)-methoxy]methoxy] guanine against cytomegalovirus and herpes simplex virus.
    Kim HT; Kim DK; Kim YW; Kim KH; Sugiyama Y; Kikuchi M
    Antiviral Res; 1995 Nov; 28(3):243-51. PubMed ID: 8629816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of BMS-180194 against experimental cytomegalovirus infections in immunocompromised mice.
    Yang H; Drain RL; Franco CA; Clark JM
    Antiviral Res; 1996 Mar; 29(2-3):233-41. PubMed ID: 8739602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new class of acyclic phosphonate nucleotide analogues: phosphonate isosteres of acyclovir and ganciclovir monophosphates as antiviral agents.
    Kim CU; Misco PF; Luh BY; Hitchcock MJ; Ghazzouli I; Martin JC
    J Med Chem; 1991 Jul; 34(7):2286-94. PubMed ID: 1648622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging assay for the convenient evaluation of antiviral compounds against cytomegalovirus in mice.
    Yamada S; Kosugi I; Katano H; Fukui Y; Kawasaki H; Arai Y; Kurane I; Inoue N
    Antiviral Res; 2010 Oct; 88(1):45-52. PubMed ID: 20633578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of ganciclovir phosphonate by cellular GMP kinase determines the stereoselectivity of anti-human cytomegalovirus activity.
    Miller WH; Beauchamp LM; Meade E; Reardon JE; Biron KK; Smith AA; Goss CA; Miller RL
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):341-56. PubMed ID: 10772719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
    Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
    Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis.
    Bolger G; Lapeyre N; Rhéaume M; Kibler P; Bousquet C; Garneau M; Cordingley M
    Antiviral Res; 1999 Dec; 44(3):155-65. PubMed ID: 10651067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on herpesvirus infections.
    Griffiths P
    J R Coll Physicians Lond; 1998; 32(3):199-202. PubMed ID: 9670143
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective inhibition of cytomegaloviruses by 9-(3'-ethylphosphono-1'-hydroxymethyl-1'-propyloxy-methyl)g uanine.
    Barnard DL; Huffman JH; Sidwell RW; Reist EJ
    Antiviral Res; 1993 Sep; 22(1):77-89. PubMed ID: 8250544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.
    Lenzo JC; Shellam GR; Lawson CM
    Antimicrob Agents Chemother; 2001 May; 45(5):1444-9. PubMed ID: 11302808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiviral activity of 3-substituted derivatives of 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purines, tricyclic analogues of acyclovir and ganciclovir.
    Boryski J; Golankiewicz B; De Clercq E
    J Med Chem; 1991 Aug; 34(8):2380-3. PubMed ID: 1652016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovir.
    Cole NL; Balfour HH
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):255-61. PubMed ID: 3032503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegaloviruses.
    Duke AE; Smee DF; Chernow M; Boehme R; Matthews TR
    Antiviral Res; 1986 Aug; 6(5):299-308. PubMed ID: 3021055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of antiviral immunotoxin and ganciclovir or cidofovir for the treatment of murine cytomegalovirus infections.
    Smee DF; Sidwell RW; Barnett BB
    Antiviral Res; 1996 Nov; 32(3):165-71. PubMed ID: 8955511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricyclic nucleoside analogues as antiherpes agents.
    Golankiewicz B; Ostrowski T
    Antiviral Res; 2006 Sep; 71(2-3):134-40. PubMed ID: 16780965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose and duration-dependence of ganciclovir treatment against murine cytomegalovirus infection in severe combined immunodeficient mice.
    Duan J; Paris W; Kibler P; Bousquet C; Liuzzi M; Cordingley MG
    Antiviral Res; 1998 Oct; 39(3):189-97. PubMed ID: 9833959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.